250 related articles for article (PubMed ID: 2717620)
1. Saposin A: second cerebrosidase activator protein.
Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
[TBL] [Abstract][Full Text] [Related]
2. Saposin D: a sphingomyelinase activator.
Morimoto S; Martin BM; Kishimoto Y; O'Brien JS
Biochem Biophys Res Commun; 1988 Oct; 156(1):403-10. PubMed ID: 2845979
[TBL] [Abstract][Full Text] [Related]
3. Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient.
Ito K; Takahashi N; Takahashi A; Shimada I; Arata Y; O'Brien JS; Kishimoto Y
Eur J Biochem; 1993 Jul; 215(1):171-9. PubMed ID: 8344278
[TBL] [Abstract][Full Text] [Related]
4. Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.
Weiler S; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
Protein Sci; 1995 Apr; 4(4):756-64. PubMed ID: 7613473
[TBL] [Abstract][Full Text] [Related]
5. Structural and membrane-binding properties of saposin D.
Tatti M; Salvioli R; Ciaffoni F; Pucci P; Andolfo A; Amoresano A; Vaccaro AM
Eur J Biochem; 1999 Jul; 263(2):486-94. PubMed ID: 10406958
[TBL] [Abstract][Full Text] [Related]
6. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
9. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
Qi X; Leonova T; Grabowski GA
J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.
Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
[TBL] [Abstract][Full Text] [Related]
13. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.
Paton BC; Poulos A
Biochem J; 1988 Aug; 254(1):77-84. PubMed ID: 3178760
[TBL] [Abstract][Full Text] [Related]
15. Specificity of low molecular weight glycoprotein effector of lipid glycosidase.
Ho MW
FEBS Lett; 1975 May; 53(2):243-7. PubMed ID: 1140409
[No Abstract] [Full Text] [Related]
16. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
17. Analysis of recombinant human saposin A expressed by Pichia pastoris.
Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
[TBL] [Abstract][Full Text] [Related]
18. Interaction of saposins, acidic lipids, and glucosylceramidase.
Morimoto S; Kishimoto Y; Tomich J; Weiler S; Ohashi T; Barranger JA; Kretz KA; O'Brien JS
J Biol Chem; 1990 Feb; 265(4):1933-7. PubMed ID: 2298731
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
Lamontagne S; Potier M
J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
[TBL] [Abstract][Full Text] [Related]
20. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]